The cyclooxygenase inhibitor flurbiprofen reduces radiation-induced angiogenic growth factor secretion of squamous cell carcinoma cell lines

Annals of the New York Academy of Sciences

Volumn 1030, Issue , 2004, Pages 37-42

  Brieger, Jürgen ^a   Schroeder, Petra ^a   Gosepath, Jan ^a   Mann, Wolf J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

bFGF; Cox; Flurbiprofen; Radiation; SCC; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FLURBIPROFEN; PROSTAGLANDIN SYNTHASE INHIBITOR; VASCULOTROPIN;

CANCER RADIOTHERAPY; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVASCULARIZATION; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE;

EID: 15044358959     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1329.005     Document Type: Conference Paper

References (14)

1. PARIS, F., Z. FUKS, A. KANG, et al. 2001. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293: 293-297.
2. KRAMER, M., C. SACHSENMAIERM, P. HERRLICH, et al. 1993. UV irradiation-induced interleukin-1 and basic fibroblast growth factor synthesis and release mediate part of the UV response. J. Biol. Chem. 268: 6734-6741.
3. ANDO, S., K. NOJIMA, H. MAJIMA, et al. 1998. Evidence for mRNA expression of vascular endothelial growth factor by X-ray irradiation in a lung squamous carcinoma cell line. Cancer Lett. 132: 75-80.
4. KOSMADAKI, M.G., M. YAAR, B.L. ARBLE, et al. 2003. UV induces VEGF through a TNF-α independent pathway. FASEB J. 17: 446-448.
5. SCHMIDT-ULLRICH, R.K., J.N. CONTESSA, G. LAMMERING, et al. 2003. ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene 22: 5855-5865.
6. GORSKI, D.H., M.A. BECKETT, N.T. JASKOWIAK, et al. 1999. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 59: 3374-3378.
7. CHURCH, R.D., J.W. FLESHMAN & H.L. MCLEOD. 2003. Cyclo-oxygenase 2 inhibition in colorectal cancer therapy. Br. J. Surg. 90: 1055-1067.
8. PETKOVA, D.K., C. CLELLAND, J. RONAN, et al. 2004. Overexpression of cyclooxygenase-2 in non-small cell lung cancer. Respir. Med. 98: 164-172.
9. CHEN, Q., N. SHINOHARA, T. ABE, et al. 2004. Significance of COX-2 expression in human renal cell carcinoma cell lines. Int. J. Cancer 108: 825-832.
10. SAWAOKA, H., S. TSUJI, M. TSUJII, et al. 1999. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab. Invest. 79: 1469-1477.
11. VLACHTSIS, K., J. BRIEGER, D.W. KIM, et al. 2002. Quantitative analysis of VEGF-isoforms in head and neck squamous cell carcinoma cell lines: relation to xenotrans-plantability and tumor progression in mice. Oncol. Rep. 9: 1133-1138.
12. WELKOBORSKY, H.J., R. JACOB, S.H. RIAZIMAND, et al. 2003. Molecular biologic characteristics of seven new cell lines of squamous cell carcinomas of the head and neck and comparison to fresh tumor tissue. Oncology 65: 60-71.
13. LEE, C.G., M. HEIJN, E. DI TOMASO, et al. 2000. Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res. 60: 5565-5570.
14. NING, S., D. LAIRD, J.M. CHERRINGTON, et al. 2002. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation. Radiat. Res. 157: 45-55.